Board of Directors

Erez Aminov is an experienced biotechnology consultant and investor. Since 2023, he has been the CEO & Chairman of the Board at Mira Pharmaceuticals (NASDAQ), initially joining the company as a consultant in 2022. His invaluable contributions and strategic acumen led to his rapid promotion to CEO. Before ascending to leadership at Mira Pharmaceuticals, Mr. Aminov established Locate Venture Corp in September 2021, committing himself to advancing and supporting early-stage biotech startups.

Mr. Aminov embarked on his journey in the biotech consulting sector in 2021, a move that marked the beginning of a career characterized by influential consulting roles with various biotech companies. With over two decades of experience, he has cultivated a robust skill set tailored to meet the biotech industry's unique challenges, including creating strategic alliances and guiding startups toward growth and prosperity.

Mr. Aminov earned a B.A. in Accounting from Touro University in New York, which helped shape his financial insight. At Mira Pharmaceuticals, he leads through informed decision-making, an essential attribute in navigating the nuances of the public sector. Drawing on his years of experience in financial expertise, he instills confidence in his ability to guide a publicly traded company through the complexities of the market.

Dr. Matthew P. Del Giudice has practiced as a radiologist since 2014. He is a general overnight emergency radiologist at the Cleveland Clinic and a real estate investor with Comfort Living, LLC. Before joining the Cleveland Clinic, from March 2021 to May 2022, Dr. Del Giudice was a general radiologist with Radiology and Imaging Specialists in Phoenix, Arizona. From July 2015 to February 2021, Dr. Del Giudice was a radiologist with Radiology Partners Phoenix, and from July 2014 to June 2015, he practiced as a musculoskeletal radiologist at the University of Arizona Health Sciences Center – Tucson. Dr. Del Giudice received his B.S. from the University of Illinois at Urbana-Champaign, his M.D. from Loyola University Stritch School of Medicine, completed his radiology residency at Loyola University Medical Center, and his musculoskeletal radiology fellowship at the University of Arizona Health Sciences Center – Tucson. Dr. Del Giudice is licensed to practice medicine in Florida and Ohio.

Mr. Jerman has served as the managing partner at Hollywell Partners, a professional accounting and finance consulting firm, since May 2019, and has provided chief financial officer and other services to multiple private equity-backed companies in the energy, SaaS, and manufacturing industries. Prior to his role with Hollywell Partners, he was a Director with PwC in the US and UK from January 2007 to August of 2019 and was a Captain with the United States Air Force from July 2003 to June 2015. He has led global public and private client engagements in the industries of retail and consumer, energy, utilities and mining, and transportation and logistics. Mr. Jerman has significant experience in client equity and debt offerings, business combinations inclusive of public listing and reporting requirements, initial valuations and ongoing goodwill impairment analyses, share-based awards, restructuring, and global taxes, as well as stakeholder management, specifically with board and management presentation experience to include annual and quarterly requirements, fee negotiations, technical accounting and finance discussions, and fraud and non-compliance investigations. Mr. Jerman has specialized in rapid project mobilization and deployment of skilled resources for emergency issues, design, and implementation of small to large scale assurance requirements and advisory projects. Mr. Jerman’s additional experience includes leading PwC’s data acquisition methods and tools, client acquisitions and systems implementations to include new SOX-compliant control plan implementations across multiple systems, leading co-sourced internal audit projects, and time spent driving PwC’s lean efficiency initiatives. Mr. Jerman was a member of the PwC national office within the SEC PCAOB quality group supporting Europe and the EMEA regions with complex accounting and audit consultations. Mr. Jerman also serves as a member of the board of directors of Inhibitor Therapeutics, Inc. (OTC:INTI). He earned a B.S. in accounting from the University of South Florida, an M.S. in accounting from the University of Tampa, and an M.B.A. from the University of Oxford. Mr. Jerman is a licensed Certified Public Accountant in Florida.

Ned MacPherson currently serves as Chief Growth Officer for Power Digital, an industry-leading digital marketing agency. Before joining Power Digital, from May 2016 to December 2023, he served as CEO and Head of Growth for Endrock Growth & Analytics, a company he founded and sold to Power Digital. Prior to founding Endrock Growth & Analytics, Mr. MacPherson held senior marketing and leadership positions at sunglass maker Prive Revaux (March 2018 to April 2020), curated meal company Menud (October 2014 to April 2018) and Rejuvenetics, LLC, a distributor of health and wellness products (December 2012 to March 2016). Mr. Macpherson holds a BA in Economics from Gettysburg College.

Dr. Denil N. Shekhat has been a radiologist since 2014 and currently practices at DNS Teleradiology in Wellington, Florida. Before starting DNS Teleradiology, Dr. Shekhat was a musculoskeletal specialist for Radiology Associates of Florida/ Radiology Partners from July 2018 to December 2023. From July 2015 to August 2018, Dr. Shekhat practiced as a general and musculoskeletal radiologist with Bethesda Radiology Associates. Dr. Shekhat received his B.A. in economics from Bowdoin College, his M.D. from the University of Tennessee Health Science Center, College of Medicine, completed his radiology residency at Baptist Memorial Hospital and his musculoskeletal radiology fellowship at the University of Arizona. Dr. Shekhat is currently licensed to practice medicine in Florida.